HHLA2 and cancer: Given that HHLA2 is overexpressed in various types of cancer cells and plays a heterogeneous prognostic role, it is critical to elucidate the molecular mechanisms regulating HHLA2 expression in order to best devise new strategies for targeting this pathway and selecting cancer patients who would optimally benefit.